| CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
12.82% |
$30M |
|
2.38M |
|
Cormorant Asset Management, LP |
Nov 3, 2025 |
| CABA |
Cabaletta Bio, Inc. |
Common Stock, par value $0.00001 per share |
9.99% |
$22.4M |
$10.7M |
9.59M |
+91.8% |
Cormorant Asset Management, LP |
Sep 30, 2025 |
| IBIO |
iBio, Inc. |
Common Stock, $0.001 par value per share |
9.99% |
$1.79M |
|
2.25M |
|
Cormorant Asset Management, LP |
Sep 30, 2025 |
| CRGX |
CARGO Therapeutics, Inc. |
Common stock, par value $0.001 per share |
7.33% |
$13.7M |
|
3.38M |
|
Cormorant Asset Management, LP |
Mar 31, 2025 |
| RAPP |
Rapport Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
6.7% |
$94.8M |
|
3.19M |
|
Cormorant Asset Management, LP |
Sep 30, 2025 |
| BIOA |
BioAge Labs, Inc. |
Common Stock, par value $0.00001 per share |
5.97% |
$10.3M |
-$2.35M |
2.14M |
-18.6% |
Cormorant Asset Management, LP |
Jun 30, 2025 |
| PRAX |
Praxis Precision Medicines, Inc. |
Common Stock, par value $0.0001 per share |
4% |
$53M |
-$33.1M |
1M |
-38.5% |
Cormorant Asset Management, LP |
Sep 30, 2025 |
| BMEA |
Biomea Fusion, Inc. |
Common Stock |
1.53% |
$2.14M |
-$5.3M |
1.06M |
-71.2% |
Chen Bihua |
Oct 22, 2025 |
| OKUR |
OnKure Therapeutics, Inc. |
Class A Common Stock, par value $0.0001 per share |
0% |
$0 |
|
0 |
|
Cormorant Asset Management, LP |
May 15, 2025 |
| KALA |
KALA BIO, Inc. |
Common Stock, $0.001 par value per share |
0% |
$0 |
-$964K |
0 |
-100% |
Cormorant Asset Management, LP |
Sep 30, 2025 |
| VYNE |
VYNE Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
-$455K |
0 |
-100% |
Cormorant Asset Management, LP |
Sep 30, 2025 |